| Sign In to gain access to subscriptions and/or personal tools. |
Development of systemic lupus erythematosus in a rheumatoid arthritis patient with anti-ribosomal P protein antibodyThe Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo
The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo
The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo
The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo
The Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo
Department of Clinical Immunology and AIDS Research Center, The Institute of Medical Science, University of Tokyo, Tokyo, Japan We describe a patient with rheumatoid arthritis (RA) whose sera contained a high titre of an antibody targeting cytoplasmic ribosomal P proteins (anti-P). This association preceded by 6 years the development of serological and clinical manifestations of systemic lupus erythematosus (SLE). The clinical significance of anti-P for the diagnosis of SLE is discussed.
Key Words: systemic lupus erythematosus rheumatoid arthritis anti-ribosomal P protein antibody
Lupus, Vol. 6, No. 9,
734-736 (1997) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


